| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2226 |
| Trial ID | NCT04148430 |
| Disease | B-Cell Non-Hodgkin's Lymphoma | B-Cell Acute Lymphoblastic Leukemia | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Co-treatment | Anakinra |
| Phase | Phase2 |
| Recruitment status | Active, Not Recruiting |
| Title | A Study of Anakinra to Prevent or Treat Severe Side Effects for Patients Receiving CAR-T Cell Therapy |
| Year | 2019 |
| Country | United States |
| Company sponsor | Memorial Sloan Kettering Cancer Center |
| Other ID(s) | 19-168 |
| Cohort 1 | |||||||
|
|||||||